Erythromycin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Erythromycin
Generic name: ERYTHROMYCIN
Manufacturer: Cardinal Health 107, LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: ba4f06c3-ebce-4896-a5cc-59bb5c2cb4e5
SPL ID: 9d665cf2-acb7-468c-9e45-09914584c4fa
Version: 9
Effective date: 2026-04-27
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:43:55

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	064067	derived:openfda.application_number
application number		ANDA064067	openfda.application_number
brand name		Erythromycin	openfda.brand_name
generic name		ERYTHROMYCIN	openfda.generic_name
manufacturer name		Cardinal Health 107, LLC	openfda.manufacturer_name
ndc	package	55154-7850-0	openfda.package_ndc
ndc	product	55154-7850	openfda.product_ndc
ndc11	package	55154785000	derived:openfda.package_ndc
rxcui		310149	openfda.rxcui
spl id		9d665cf2-acb7-468c-9e45-09914584c4fa	id
spl set id		ba4f06c3-ebce-4896-a5cc-59bb5c2cb4e5	set_id
unii		63937KV33D	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions. To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.